dactinomycin has been researched along with von Hippel-Lindau Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Klausner, RD; Lee, S; Neumann, M; Pause, A; Pavlakis, GN; Stauber, R; Stearman, R | 1 |
1 other study(ies) available for dactinomycin and von Hippel-Lindau Disease
Article | Year |
---|---|
Transcription-dependent nuclear-cytoplasmic trafficking is required for the function of the von Hippel-Lindau tumor suppressor protein.
Topics: Animals; Base Sequence; Biological Transport, Active; Carcinoma, Renal Cell; Cell Fusion; Cell Nucleus; COS Cells; Cytoplasm; Dactinomycin; DNA Primers; Genes, Tumor Suppressor; Green Fluorescent Proteins; HeLa Cells; Humans; Kidney Neoplasms; Ligases; Luminescent Proteins; Mutation; Proteins; Recombinant Fusion Proteins; Transcription, Genetic; Tumor Cells, Cultured; Tumor Suppressor Proteins; Ubiquitin-Protein Ligases; von Hippel-Lindau Disease; Von Hippel-Lindau Tumor Suppressor Protein | 1999 |